| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1697d346714d43cb7a97240d89cf0c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_329cbcffe1ddb8987b36f1293c1d2a87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70bc776c1610d8c85e87115d84e0e9af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f70262efd0c9aaba0e641a2446a763d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbfb1c518e0ee5f8310c2873b9628c56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-787 |
| filingDate |
2006-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a74564f9c8cfaca501b68c605e90d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b3edeb11aab78a79f5acd40d86c29aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ff974d39f525e7b26e50af33d33197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a276b686208dd44636974a34e7b1ff7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a24ac7832dc5e1c380fe12944ea3d32 |
| publicationDate |
2007-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007003513-A1 |
| titleOfInvention |
Polymerized and modified rapamycins and their use in coating medical prostheses |
| abstract |
Compositions of matter comprise linked pluralities of mTOR-binding molecules, such as rapamycin. The compositions may be directly polymerized or may comprise rapamycin or other mTOR-binding molecules covalently or non-covalently attached to a backbone molecule. The compositions may be bound to vascular prostheses and other implantable devices in order to inhibit hyperplasia or for other therapeutic purposes. |
| priorityDate |
2002-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |